Sbi Securities Co., Ltd. Minerva Neurosciences, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 162 shares of NERV stock, worth $285. This represents 0.0% of its overall portfolio holdings.
Number of Shares
162
Previous 53
205.66%
Holding current value
$285
Previous $90,000
210.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NERV
# of Institutions
20Shares Held
1.95MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA1.35MShares$2.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA252KShares$443,6250.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny111KShares$195,3600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA75.6KShares$133,1000.0% of portfolio
-
Black Rock Inc. New York, NY72.7KShares$127,8970.0% of portfolio
About Minerva Neurosciences, Inc.
- Ticker NERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,340,190
- Market Cap $9.4M
- Description
- Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...